ArticleGynecologic oncology reports2025

Exceptional response to trastuzumab deruxtecan in recurrent neuroendocrine cervical cancer: A case report.

Lauren Tostrud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.